Literature DB >> 8308653

Prolonged exposure of Plasmodium falciparum to ciprofloxacin increases anti-malarial activity.

A E Yeo1, K H Rieckmann.   

Abstract

The minimum inhibitory concentration (MIC) of ciprofloxacin was determined for 2 isolates of Plasmodium falciparum at 48, 96, and 144 hr. The MIC decreased from mean values of 28.1 micrograms/ml for the FC isolate and 27.2 micrograms/ml for the K1 isolate at 48 hr to 2.8 micrograms/ml and 4.4 micrograms/ml, respectively, at 96 hr. Concentrations of 0.1-1.0 micrograms/ml were effective in suppressing parasite growth over 144 hr of incubation. These findings indicate that the multiplication of malaria parasites can be inhibited by clinically achievable concentrations of ciprofloxacin provided that exposure to the drug is prolonged over several asexual erythrocytic cycles. They also raise the possibility that this antibiotic could be used eventually, in combination with a rapidly acting but noncurative drug regimen, to treat patients with refractory falciparum infections.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8308653

Source DB:  PubMed          Journal:  J Parasitol        ISSN: 0022-3395            Impact factor:   1.276


  8 in total

1.  In vitro activities of antibiotics against Plasmodium falciparum are inhibited by iron.

Authors:  B Pradines; C Rogier; T Fusai; J Mosnier; W Daries; E Barret; D Parzy
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

2.  Interaction between ciprofloxacin and chloroquine in mice infected with chloroquine resistant Plasmodium berghei: interaction between ciprofloxacin and chloroqune.

Authors:  Grace Olusola Gbotosho; Christian T Happi; Olutayo Woranola; Oyindamola O Abiodun; Akin Sowunmi; Ayoade M Oduola
Journal:  Parasitol Res       Date:  2011-08-09       Impact factor: 2.289

3.  Treatment and control of mycoplasma contamination in Plasmodium falciparum culture.

Authors:  Shubhra Singh; S K Puri; Kumkum Srivastava
Journal:  Parasitol Res       Date:  2008-09-30       Impact factor: 2.289

4.  In vitro activities of 25 quinolones and fluoroquinolones against liver and blood stage Plasmodium spp.

Authors:  Nassira Mahmoudi; Liliane Ciceron; Jean-François Franetich; Khemais Farhati; Olivier Silvie; Wijnand Eling; Robert Sauerwein; Martin Danis; Dominique Mazier; Francis Derouin
Journal:  Antimicrob Agents Chemother       Date:  2003-08       Impact factor: 5.191

5.  Telithromycin and quinupristin-dalfopristin induce delayed death in Plasmodium falciparum.

Authors:  Diana Barthel; Martin Schlitzer; Gabriele Pradel
Journal:  Antimicrob Agents Chemother       Date:  2007-12-03       Impact factor: 5.191

Review 6.  Antibiotics in malaria therapy: which antibiotics except tetracyclines and macrolides may be used against malaria?

Authors:  Tiphaine Gaillard; Marylin Madamet; Francis Foguim Tsombeng; Jérôme Dormoi; Bruno Pradines
Journal:  Malar J       Date:  2016-11-15       Impact factor: 2.979

Review 7.  Antiviral, antifungal, and antiparasitic activities of fluoroquinolones optimized for treatment of bacterial infections: a puzzling paradox or a logical consequence of their mode of action?

Authors:  A Dalhoff
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-12-17       Impact factor: 3.267

Review 8.  Repurposing Drugs to Fight Hepatic Malaria Parasites.

Authors:  Diana Fontinha; Isabel Moules; Miguel Prudêncio
Journal:  Molecules       Date:  2020-07-28       Impact factor: 4.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.